Altamira Therapeutics announces publication of preclinical data on SOD2 mRNA

Altamira Therapeutics announced the preprint publication of a study demonstrating effective treatment of abdominal aortic aneurysm in an animal model. The study was conducted by a research group from Washington University, St. Louis MO, and the University of South Florida, Tampa FL. It showed that treatment with SOD2 mRNA delivered systemically with peptide-based nanoparticles to AAA mice resulted in a significant reduction in aorta dilation, delayed rupture and a highly significant improvement in survival rates compared to untreated controls. Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic aneurysm. Positive outcomes suggest potential use of treatment in management of small abdominal aortic aneurysm and prevention of ruptures .